Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3642853019 | Product containing ocrelizumab (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3715973010 | Ocrelizumab-containing product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 1237101000172112 | produit contenant de l'ocrélizumab | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| 1225891000172115 | product dat ocrelizumab bevat | nl | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing ocrelizumab (medicinal product) | Has active ingredient | Ocrelizumab | true | Inferred relationship | Some | 1 | |
| Product containing ocrelizumab (medicinal product) | Is a | Product containing monoclonal antibody (product) | true | Inferred relationship | Some | ||
| Product containing ocrelizumab (medicinal product) | Is a | Product containing immunomodulator (product) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ocrelizumab-containing product in parenteral dose form | Is a | True | Product containing ocrelizumab (medicinal product) | Inferred relationship | Some | |
| Ocrelizumab only product | Is a | True | Product containing ocrelizumab (medicinal product) | Inferred relationship | Some |
Reference Sets
FHIR